×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

Decision on additional vaccine dose deferred in India

  634 Views

eMediNexus    07 December 2021

The advisory group on COVID immunization has put off any decision on an additional vaccine dose as there was no consensus on whether there is a need to administer a booster jab to people at high risk of infection or severe illness due to COVID-19. A senior official said that the National Technical Advisory Group on Immunisation (NTAGI) has not made any recommendation yet.

Experts are more inclined towards protecting the immunocompromised children with vaccination, and the guidelines for the same will likely be submitted by the end of this week. NTAGI for COVID-19 has evaluated data which shows that there is high seropositivity in the Indian population, stated sources. 

An official said that the NTAGI will wait for the WHO’s guidance on the matter and discuss again… (ET Healthworld – TNN, December 7, 2021)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.